180 related articles for article (PubMed ID: 24849536)
1. High serum parathyroid hormone and calcium are risk factors for hypertension in Japanese patients.
Yagi S; Aihara K; Kondo T; Endo I; Hotchi J; Ise T; Iwase T; Akaike M; Matsumoto T; Sata M
Endocr J; 2014; 61(7):727-33. PubMed ID: 24849536
[TBL] [Abstract][Full Text] [Related]
2. Normocalcemic Primary Hyperparathyroidism: A Comparison with the Hypercalcemic Form in a Tertiary Referral Population.
Pierreux J; Bravenboer B
Horm Metab Res; 2018 Nov; 50(11):797-802. PubMed ID: 30396209
[TBL] [Abstract][Full Text] [Related]
3. The prevalence of undiagnosed and unrecognized primary hyperparathyroidism: a population-based analysis from the electronic medical record.
Press DM; Siperstein AE; Berber E; Shin JJ; Metzger R; Monteiro R; Mino J; Swagel W; Mitchell JC
Surgery; 2013 Dec; 154(6):1232-7; discussion 1237-8. PubMed ID: 24383100
[TBL] [Abstract][Full Text] [Related]
4. Increased prevalence of primary hyperparathyroidism in treated breast cancer.
Fierabracci P; Pinchera A; Miccoli P; Conte PF; Vignali E; Zaccagnini M; Marcocci C; Giani C
J Endocrinol Invest; 2001 May; 24(5):315-20. PubMed ID: 11407650
[TBL] [Abstract][Full Text] [Related]
5. Normocalcemic primary hyperparathyroidism: evidence for a generalized target-tissue resistance to parathyroid hormone.
Maruani G; Hertig A; Paillard M; Houillier P
J Clin Endocrinol Metab; 2003 Oct; 88(10):4641-8. PubMed ID: 14557434
[TBL] [Abstract][Full Text] [Related]
6. Parathyroid hormone, aldosterone-to-renin ratio and fibroblast growth factor-23 as determinants of nocturnal blood pressure in primary hyperparathyroidism: the eplerenone in primary hyperparathyroidism trial.
Verheyen N; Fahrleitner-Pammer A; Pieske B; Meinitzer A; Belyavskiy E; Wetzel J; Gaksch M; Grübler MR; Catena C; Sechi LA; Van Ballegooijen AJ; Brandenburg VM; Scharnagl H; Perl S; Brussee H; März W; Pilz S; Tomaschitz A
J Hypertens; 2016 Sep; 34(9):1778-86. PubMed ID: 27379537
[TBL] [Abstract][Full Text] [Related]
7. Is Normocalcemic Primary Hyperparathyroidism Harmful or Harmless?
Chen G; Xue Y; Zhang Q; Xue T; Yao J; Huang H; Liang J; Li L; Lin W; Lin L; Shi L; Cai L; Wen J
J Clin Endocrinol Metab; 2015 Jun; 100(6):2420-4. PubMed ID: 25668199
[TBL] [Abstract][Full Text] [Related]
8. Parathyroid hormone and parathyroid hormone related protein assays in the investigation of hypercalcemic patients in hospital in a Chinese population.
Lee JK; Chuang MJ; Lu CC; Hao LJ; Yang CY; Han TM; Lam HC
J Endocrinol Invest; 1997; 20(7):404-9. PubMed ID: 9309539
[TBL] [Abstract][Full Text] [Related]
9. [The relation between serum levels of calcium and PTH and the positivity of parathyroid scintigraphy with sestamibi--analysis of 194 patients].
Duarte PS; Decker HH; Aldighieri FC; Brandão C; Alonso G; Vieira JG
Arq Bras Endocrinol Metabol; 2005 Dec; 49(6):930-7. PubMed ID: 16544016
[TBL] [Abstract][Full Text] [Related]
10. Low urine calcium excretion in African American patients with primary hyperparathyroidism.
Taha W; Singh N; Flack JM; Abou-Samra AB
Endocr Pract; 2011; 17(6):867-72. PubMed ID: 21613053
[TBL] [Abstract][Full Text] [Related]
11. Long-term effects of intravenous calcitriol therapy on the control of secondary hyperparathyroidism.
Malberti F; Corradi B; Cosci P; Calliada F; Marcelli D; Imbasciati E
Am J Kidney Dis; 1996 Nov; 28(5):704-12. PubMed ID: 9158208
[TBL] [Abstract][Full Text] [Related]
12. Persistent elevation in serum parathyroid hormone levels in normocalcemic patients after parathyroidectomy: does it matter?
Carsello CB; Yen TW; Wang TS
Surgery; 2012 Oct; 152(4):575-81; discussion 581-3. PubMed ID: 23021134
[TBL] [Abstract][Full Text] [Related]
13. Normocalcemic, subclinical, asymptomatic primary hyperparathyroidism in patients with goiter or papillary thyroid cancer--preliminary report. Normocalcemic primary hyperparathyroidism and thyroid pathology.
Niedźwiecki S; Kuzdak K; Kaczka K; Pomorski L
Wiad Lek; 2007; 60(5-6):228-30. PubMed ID: 17966885
[TBL] [Abstract][Full Text] [Related]
14. Oral vitamin D supplementation reduces the incidence of eucalcemic PTH elevation after surgery for primary hyperparathyroidism.
Beyer TD; Solorzano CC; Prinz RA; Babu A; Nilubol N; Patel S
Surgery; 2007 Jun; 141(6):777-83. PubMed ID: 17560254
[TBL] [Abstract][Full Text] [Related]
15. Parathyroidectomy for Normocalcemic Tertiary Hyperparathyroidism: A 19-Year Experience.
Ramonell KM; Lindeman B; Chen H; Fazendin J
J Surg Res; 2022 Aug; 276():362-368. PubMed ID: 35429685
[TBL] [Abstract][Full Text] [Related]
16. Biochemical and Skeletal Outcomes of Parathyroidectomy for Normocalcemic (Incipient) Primary Hyperparathyroidism.
Sho S; Kuo EJ; Chen AC; Li N; Yeh MW; Livhits MJ
Ann Surg Oncol; 2019 Feb; 26(2):539-546. PubMed ID: 30406488
[TBL] [Abstract][Full Text] [Related]
17. Coexisting primary hyperparathyroidism and sarcoidosis cause increased angiotensin-converting enzyme and decreased parathyroid hormone and phosphate levels.
Lim V; Clarke BL
J Clin Endocrinol Metab; 2013 May; 98(5):1939-45. PubMed ID: 23493435
[TBL] [Abstract][Full Text] [Related]
18. Sporadic primary hyperparathyroidism and stone disease: a comprehensive metabolic evaluation before and after parathyroidectomy.
Marchini GS; Faria KVM; Torricelli FCM; Monga M; Srougi M; Nahas WC; Mazzucchi E
BJU Int; 2018 Feb; 121(2):281-288. PubMed ID: 29124877
[TBL] [Abstract][Full Text] [Related]
19. Population-based screening for primary hyperparathyroidism with serum calcium and parathyroid hormone values in menopausal women.
Lundgren E; Rastad J; Thrufjell E; Akerström G; Ljunghall S
Surgery; 1997 Mar; 121(3):287-94. PubMed ID: 9092129
[TBL] [Abstract][Full Text] [Related]
20. Twenty-four hour Holter ECG in normocalcemic and hypercalcemic patients with hyperparathyroidism.
Pepe J; Magna A; Sonato C; Sgreccia A; Colangelo L; Occhiuto M; Cilli M; Minisola S; Cipriani C
J Endocrinol Invest; 2024 Jun; 47(6):1499-1504. PubMed ID: 38141155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
